{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:20:00Z","timestamp":1781137200451,"version":"3.54.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA 217889"],"award-info":[{"award-number":["CA 217889"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.mayocp.2019.06.007","type":"journal-article","created":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T23:11:42Z","timestamp":1577142702000},"page":"395-405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Routine Childhood Vaccines Given in the First 11 Months of Life"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6355-8752","authenticated-orcid":false,"given":"Robert M.","family":"Jacobson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.mayocp.2019.06.007_bib1","first-page":"241","article-title":"Ten great public health achievements\u2014United States, 1900-1999","volume":"48","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"29","key":"10.1016\/j.mayocp.2019.06.007_bib2","first-page":"621","article-title":"Achievements in public health, 1900-1999: control of infectious diseases","volume":"48","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"19","key":"10.1016\/j.mayocp.2019.06.007_bib3","first-page":"619","article-title":"Ten great public health achievements\u2014United States, 2001-2010","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.mayocp.2019.06.007_bib4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.15585\/mmwr.mm6805a4","article-title":"Advisory Committee on Immunization Practices recommended immunization schedule for children and adolescents aged 18 years or younger\u2014United States, 2019","volume":"68","author":"Robinson","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.mayocp.2019.06.007_bib5","author":"World Health Organization"},{"key":"10.1016\/j.mayocp.2019.06.007_bib7","series-title":"Epidemiology and Prevention of Vaccine-Preventable Diseases","year":"2015"},{"issue":"1","key":"10.1016\/j.mayocp.2019.06.007_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Recomm Rep"},{"issue":"7","key":"10.1016\/j.mayocp.2019.06.007_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1358\/dot.2018.54.7.2833984","article-title":"Heplisav-B vaccination for the prevention of hepatitis B virus infection in adults in the United States","volume":"54","author":"Splawn","year":"2018","journal-title":"Drugs Today (Barc)"},{"issue":"25","key":"10.1016\/j.mayocp.2019.06.007_bib11","first-page":"549","article-title":"Achievements in public health: hepatitis B vaccination\u2014United States, 1982-2002","volume":"51","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.mayocp.2019.06.007_bib12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1086\/653622","article-title":"The prevalence of hepatitis B virus infection in the United States in the era of vaccination","volume":"202","author":"Wasley","year":"2010","journal-title":"J\u00a0Infect Dis"},{"issue":"40","key":"10.1016\/j.mayocp.2019.06.007_bib13","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.15585\/mmwr.mm6740a4","article-title":"Vaccination coverage among children aged 19\u201335 months\u2014United States, 2017","volume":"67","author":"Hill","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.mayocp.2019.06.007_bib14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/jpids\/piu115","article-title":"Estimated annual perinatal hepatitis B virus infections in the United States, 2000-2009","volume":"5","author":"Ko","year":"2016","journal-title":"J\u00a0Pediatr Infect Dis Soc"},{"issue":"5","key":"10.1016\/j.mayocp.2019.06.007_bib15","doi-asserted-by":"crossref","first-page":"e1141","DOI":"10.1542\/peds.2014-3213","article-title":"Outcomes of infants born to women infected with hepatitis B","volume":"135","author":"Schillie","year":"2015","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.mayocp.2019.06.007_bib16","doi-asserted-by":"crossref","first-page":"E195","DOI":"10.33321\/cdi.2017.41.27","article-title":"Prevention of perinatal hepatitis B virus transmission: are we following guidelines?","volume":"41","author":"Markey","year":"2017","journal-title":"Commun Dis Intell Q Rep"},{"issue":"434","key":"10.1016\/j.mayocp.2019.06.007_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaj1748","article-title":"The impact of past vaccination coverage and immunity on pertussis resurgence","volume":"10","author":"Domenech de Celles","year":"2018","journal-title":"Sci Transl Med"},{"issue":"6","key":"10.1016\/j.mayocp.2019.06.007_bib18","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1086\/655826","article-title":"The present and future control of pertussis","volume":"51","author":"Cherry","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.mayocp.2019.06.007_bib19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1073\/pnas.1321360111","article-title":"Unraveling the challenges of pertussis","volume":"111","author":"Edwards","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.mayocp.2019.06.007_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6702a1","article-title":"Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"67","author":"Liang","year":"2018","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"10.1016\/j.mayocp.2019.06.007_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/cid\/ciw633","article-title":"Effectiveness of prenatal tetanus, diphtheria, and acellular pertussis vaccination on pertussis severity in infants","volume":"64","author":"Winter","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.mayocp.2019.06.007_bib22","doi-asserted-by":"crossref","first-page":"e20153326","DOI":"10.1542\/peds.2015-3326","article-title":"Waning Tdap effectiveness in adolescents","volume":"137","author":"Klein","year":"2016","journal-title":"Pediatrics"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2019.06.007_bib23","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1093\/infdis\/jit531","article-title":"Possible options for new pertussis vaccines","volume":"209","author":"Meade","year":"2014","journal-title":"J\u00a0Infect Dis"},{"issue":"9","key":"10.1016\/j.mayocp.2019.06.007_bib24","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1073\/pnas.1324149111","article-title":"Toward a new vaccine for pertussis","volume":"111","author":"Robbins","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.mayocp.2019.06.007_bib25","doi-asserted-by":"crossref","first-page":"ftv059","DOI":"10.1093\/femspd\/ftv059","article-title":"Strategies and new developments to control pertussis, an actual health problem","volume":"73","author":"Gaillard","year":"2015","journal-title":"Pathog Dis"},{"issue":"30","key":"10.1016\/j.mayocp.2019.06.007_bib26","first-page":"829","article-title":"Updated recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding routine poliovirus vaccination","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"RR-5","key":"10.1016\/j.mayocp.2019.06.007_bib27","first-page":"1","article-title":"Advisory Committee on Immunization Practices. Poliomyelitis prevention in the United States: updated recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"49","author":"Prevots","year":"2000","journal-title":"MMWR Recomm Rep"},{"issue":"9","key":"10.1016\/j.mayocp.2019.06.007_bib28","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.vaccine.2016.11.017","article-title":"Polio vaccines: WHO position paper, March 2016-recommendations","volume":"35","author":"World Health Organization","year":"2017","journal-title":"Vaccine"},{"issue":"35","key":"10.1016\/j.mayocp.2019.06.007_bib29","doi-asserted-by":"crossref","first-page":"992","DOI":"10.15585\/mmwr.mm6735a5","article-title":"Progress toward poliovirus containment implementation\u2014worldwide, 2017-2018","volume":"67","author":"Fournier-Caruana","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.mayocp.2019.06.007_bib30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.15585\/mmwr.mm6601a6","article-title":"Guidance for assessment of poliovirus vaccination status and vaccination of children who have received poliovirus vaccine outside the United States","volume":"66","author":"Marin","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"10.1016\/j.mayocp.2019.06.007_bib31","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJMp1808903","article-title":"Ending use of oral poliovirus vaccine: a difficult move in the polio endgame","volume":"379","author":"Pallansch","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.mayocp.2019.06.007_bib32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.idc.2017.10.005","article-title":"Changing epidemiology of Haemophilus influenzae in children","volume":"32","author":"Butler","year":"2018","journal-title":"Infect Dis Clin North Am"},{"issue":"RR-9","key":"10.1016\/j.mayocp.2019.06.007_bib33","first-page":"1","article-title":"Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"49","year":"2000","journal-title":"MMWR Recomm Rep"},{"issue":"RR-11","key":"10.1016\/j.mayocp.2019.06.007_bib34","first-page":"1","article-title":"Prevention of pneumococcal disease among infants and children: use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine\u2014recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Nuorti","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2019.06.007_bib35","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1093\/ofid\/ofx162.158","article-title":"Direct and indirect impact of 13-valent pneumococcal conjugate vaccine (PCV13) on invasive pneumococcal disease (IPD) among children and adults in the U.S","volume":"4","author":"Pilishvili","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.mayocp.2019.06.007_bib36","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.mayocp.2019.06.007_bib37","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1086\/529142","article-title":"Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory","volume":"46","author":"de Roux","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"RR-2","key":"10.1016\/j.mayocp.2019.06.007_bib38","first-page":"1","article-title":"Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"58","author":"Cortese","year":"2009","journal-title":"MMWR Recomm Rep"},{"issue":"41","key":"10.1016\/j.mayocp.2019.06.007_bib39","first-page":"1427","article-title":"Addition of history of intussusception as a contraindication for rotavirus vaccination","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.mayocp.2019.06.007_bib40","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1080\/21645515.2016.1252493","article-title":"Options for improving effectiveness of rotavirus vaccines in developing countries","volume":"13","author":"Tissera","year":"2017","journal-title":"Hum Vaccin Immunother"},{"issue":"10","key":"10.1016\/j.mayocp.2019.06.007_bib41","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2217\/fvl-2016-0082","article-title":"Rotavirus vaccines: current global impact and future perspectives","volume":"11","author":"Burnett","year":"2016","journal-title":"Future Virol"},{"issue":"3","key":"10.1016\/j.mayocp.2019.06.007_bib42","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/infdis\/jit174","article-title":"Efficacy, immunogenicity, and safety of two doses of a tetravalent rotavirus vaccine RRV-TV in Ghana with the first dose administered during the neonatal period","volume":"208","author":"Armah","year":"2013","journal-title":"J\u00a0Infect Dis"},{"issue":"3","key":"10.1016\/j.mayocp.2019.06.007_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6703a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2018-19 influenza season","volume":"67","author":"Grohskopf","year":"2018","journal-title":"MMWR Recomm Rep"},{"issue":"22","key":"10.1016\/j.mayocp.2019.06.007_bib44","doi-asserted-by":"crossref","first-page":"643","DOI":"10.15585\/mmwr.mm6722a5","article-title":"Update: ACIP recommendations for the use of quadrivalent live attenuated influenza vaccine (LAIV4)\u2014United States, 2018-19 influenza season","volume":"67","author":"Grohskopf","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.mayocp.2019.06.007_bib45","series-title":"FluMist Quadrivalent [package insert]","year":"2018"},{"issue":"4","key":"10.1016\/j.mayocp.2019.06.007_bib46","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.vaccine.2017.12.014","article-title":"Burden of medically attended influenza infection and cases averted by vaccination\u2014United States, 2013\/14 through 2015\/16 influenza seasons","volume":"36","author":"Jackson","year":"2018","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.mayocp.2019.06.007_bib47","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-2918","article-title":"Influenza-associated pediatric deaths in the United States, 2010-2016","volume":"141","author":"Shang","year":"2018","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.mayocp.2019.06.007_bib50","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1542\/peds.2006-1422","article-title":"Compliance with the recommendations for 2 doses of trivalent inactivated influenza vaccine in children less than 9 years of age receiving influenza vaccine for the first time: a Vaccine Safety Datalink study","volume":"118","author":"Jackson","year":"2006","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.mayocp.2019.06.007_bib51","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3325\/cmj.2013.54.135","article-title":"Effectiveness of seasonal influenza vaccines in children\u2014a systematic review and meta-analysis","volume":"54","author":"Luksic","year":"2013","journal-title":"Croat Med J"},{"issue":"9","key":"10.1016\/j.mayocp.2019.06.007_bib52","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.4161\/hv.29669","article-title":"Infants and the seasonal influenza vaccine: a global perspective on safety, effectiveness, and alternate forms of protection","volume":"10","author":"Moriarty","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"10.1016\/j.mayocp.2019.06.007_bib53","doi-asserted-by":"crossref","first-page":"156","DOI":"10.15585\/mmwr.mm6705e2","article-title":"Advisory Committee on Immunization Practices recommended immunization schedule for children and adolescents aged 18 years or younger\u2014United States, 2018","volume":"67","author":"Robinson","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"18","key":"10.1016\/j.mayocp.2019.06.007_bib54","doi-asserted-by":"crossref","first-page":"E843","DOI":"10.1503\/cmaj.101720","article-title":"Reducing the pain of childhood vaccination: an evidence-based clinical practice guideline","volume":"182","author":"Taddio","year":"2010","journal-title":"CMAJ"},{"issue":"4","key":"10.1016\/j.mayocp.2019.06.007_bib55","first-page":"49","article-title":"The C.A.S.E. approach: guidance for talking to vaccine-hesitant parents","volume":"96","author":"Jacobson","year":"2013","journal-title":"Minn Med"},{"issue":"6","key":"10.1016\/j.mayocp.2019.06.007_bib56","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1542\/peds.2013-2037","article-title":"The architecture of provider-parent vaccine discussions at health supervision visits","volume":"132","author":"Opel","year":"2013","journal-title":"Pediatrics"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619619305737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619619305737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:31:47Z","timestamp":1758418307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619619305737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0025619619305737"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2019.06.007","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Routine Childhood Vaccines Given in the First 11 Months of Life","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2019.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}